| | DEOXYRIBONUCLEIC ACID (DNA) APTAMER LIBRARY GENERATION SERVICES | APTAGEN LLC | $582,660 | DEFENSE HEALTH AGENCY (DHA) | DEFENSE HEALTH AGENCY (DHA) | — | 325413In-Vitro Diagnostic Substance Manufacturing | AN22HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH | Mar 25, 2025 | Mar 25, 2025 | Mar 30, 2028 |
| | THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) PURCHASE ORDER FOR DBPAP/ AMB A 1-SPECIFIC APTAMERS. | APTAGEN LLC | $100,000 | FOOD AND DRUG ADMINISTRATION | FOOD AND DRUG ADMINISTRATION | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | Sep 27, 2024 | Sep 27, 2024 | Sep 26, 2025 |
| | GLYPHOSATE APTAMER FOR THE SUGARBEET AND POTATO UNIT IN FARGO, ND. | APTAGEN LLC | $75,000 | AGRICULTURAL RESEARCH SERVICE | AGRICULTURAL RESEARCH SERVICE | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | 6640LABORATORY EQUIPMENT AND SUPPLIES | Apr 11, 2024 | Apr 11, 2024 | Feb 28, 2025 |
| | APTAMER DEVELOPMENT | APTAGEN LLC | $179,800 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | Sep 16, 2022 | Sep 20, 2022 | Sep 19, 2023 |
| | DEVELOPMENT OF APTAMERS (SYNTHETIC ANTIBODIES) FOR HIV INTEGRASE | APTAGEN LLC | $214,780 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | Q301MEDICAL- LABORATORY TESTING | Sep 17, 2021 | Sep 22, 2021 | Sep 21, 2022 |
| | SBIR PHASE II FINDING HUMAN CARRIERS OF TAENIASIS TO PREVENT NEUROCYSTICERCOSIS ASSOCIATED EPILEPSY | APTAGEN LLC | $989,300 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 238990All Other Specialty Trade Contractors | R499SUPPORT- PROFESSIONAL: OTHER | Sep 26, 2019 | Sep 30, 2019 | Sep 29, 2021 |
| | SBIR TOPIC 39 PHASE 1- FINDING HUMAN CARRIERS OF TAENIASIS TO PREVENT NEUROCYSTICERCOSIS EPILEPSY | APTAGEN LLC | $126,680 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 561450Credit Bureaus | AJ91 | Sep 19, 2018 | Sep 17, 2018 | May 31, 2019 |
| | IGF::OT::IGF APTA-BEACONS AGAINST EXCRETORY-SECRETORY ANTIGENS FROM CYSTICERCOSIS | APTAGEN LLC | $40,000 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 541711 | AZ17 | Jul 9, 2015 | Jul 9, 2015 | Jun 23, 2016 |